Gastonia Pharmacy to Pay $204,000 to Resolve Alleged Controlled Substances Act Violations
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Gastonia Pharmacy to Pay $204,000 to Resolve Alleged Controlled Substances Act Violations

Gastonia Pharmacy to Pay $204,000 to Resolve Alleged Controlled Substances Act Violations

Febrero 27, 2025
|
Share Article
|
Download Press Release
For Immediate Release
Contact: SA Crystal Harper
Phone Number: (571) 362-3433

CHARLOTTE, N.C. – Prescriptions Plus, a pharmacy in Gastonia, N.C., has agreed to pay $204,000 to resolve allegations that it violated the recordkeeping requirements of the Controlled Substances Act, announced Acting U.S. Attorney Lawrence J. Cameron. 

The Controlled Substances Act was enacted to combat illegal distribution and abuse of controlled substances, including prescription medications. Pharmacies dispensing controlled substances must register with the Drug Enforcement Administration (DEA) and comply with the various requirements of the Controlled Substances Act, including to maintain complete and accurate records of all controlled substances received, sold, or otherwise disposed of. These recordkeeping requirements play a vital role in ensuring the appropriate handling, accounting, and distribution of controlled substances. Violations of the recordkeeping requirements subject pharmacies to civil monetary penalties. 

The United States alleges that Prescriptions Plus did not adequately monitor the conduct of its staff pharmacist and failed to keep complete and accurate records regarding the receipt and distribution of controlled substances, including oxycodone and alprazolam. The United States contends that these violations negligently enabled the illegal distribution of oxycodone and alprazolam by its staff pharmacist. 

Prescriptions Plus represents that it has taken steps to improve its compliance with the Controlled Substances Act, including by implementing new recordkeeping policies. As part of the resolution, Prescriptions Plus has entered into a Memorandum of Agreement with the DEA, addressing measures to ensure the pharmacy’s future compliance with the Controlled Substances Act. 

“DEA investigators will continue to aggressively pursue the unlawful dispensing practices of pharmacists, as was the case with the pharmacist working at Prescriptions Plus. The DEA is committed to making sure healthcare providers are abiding by the law,” said Jae W. Chung, Acting Special Agent in Charge of the Atlanta Field Division of the DEA, which oversees the Charlotte District Office. 

“When pharmacies fail to comply with the Controlled Substances Act, they can put opioids and other prescription drugs at risk of abuse on the street, causing great harm to our communities,” said Acting U.S. Attorney Cameron. “Our Office is committed to working with the Drug Enforcement Administration to hold pharmacies accountable when they fail to take required steps to prevent unlawful drug distribution.” 

This investigation was conducted by the DEA Charlotte District Office Tactical Diversion Squad with assistance from the Gastonia Police Department, DEA Greensboro Resident Office Diversion Group, DEA Columbia District Office Diversion Group, North Carolina Board of Pharmacy, and IRS Charlotte Criminal Investigation Division. 

Assistant U.S. Attorney Holly H. Snow handled this affirmative civil enforcement matter on behalf of the Government. 

The claims resolved by the settlement are allegations only and there has been no determination of liability. 

Download Press Release
###
Oxycodone
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Jae W. Chung, Acting Special Agent in Charge - Atlanta
@DEAAtlantaDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster